• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pharm-Olam expands Poland facility

Pharm-Olam expands Poland facility

October 15, 2015
CenterWatch Staff

Pharm-Olam International, a Houston-based, multinational, full-service CRO, is relocating its Polish location to a larger office to accommodate a growing staff.

“We have seen a significant increase in interest in running trials in Poland and we are expanding our offices to accommodate the current and future workload,” said Sanjiv Suri, U.S. chief executive officer. “When we opened our first operating office in Poland in 1995, we had to convince potential sponsors to place their trials in this emerging country. Nowadays, Poland is near the top of the list of countries that sponsors know can produce high-quality data, on time. Our staff numbers in Poland has increased over the past few years and we anticipate a 25% growth of our staff in Poland to meet upcoming demand.”

Pharm-Olam’s Poland Country Manager Dr. Janusz Rupinski said, “With a population of almost 40 million people, Poland offers rapid recruitment in most therapeutic areas. When combining the extensive population with experienced investigational staff and the efficient transfer of study supplies as an E.U. member state, Poland is primed for extensive growth in the clinical trial arena. As of Sept. 22, 2015, there were approximately 1,150 phase I-IV active clinical trials ongoing in Poland. Of these trials, there were 396 trials registered in 2014 and 329 in 2015 to date.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing